Speaker slots available for Neuroimmunology 2019

We are very pleased to announce that our 9th Global summit on Neuroscience and Neuroimmunology is going to be held during May 22-23, 2019 at London, UK.
So hurry up and book your slot today
PS: https://bit.ly/2wgcWLt

Exploring Upcoming Knowledge of Neuro Researches @ Neuroimmunology 2019

The main theme of the conference is “Unveiling the advances in the field of Neuroscience and Neuroimmunology” which covers a wide range of critically important sessions from basic research to innovations in #Neuroscience and #Neuroimmunology.
Share your abstract @ https://bit.ly/2wgcWLt

Neuroimmunology 2019 - Best Poster Award

#PULSUS publicizes an outline of #Awards for #Young_Scientists in order to help #excellence in various fields of #Neuroscience and #Neuroimmunology
#Neuroimmunology 2019 | May 22-23, 2019 | #London | #UK

Click here to for more details: https://bit.ly/2ryHHGQ 

Track 9 : Neuroinflammation

Neuroinflammation is inflammation of the nervous tissue.  Neuroinflammation is a prominent component of several neurodegenerative diseases, including multiple sclerosis, Alzheimer's disease, Parkinson's disease, tauopathies, amyotrophic lateral sclerosis and prion diseases. Due to which the ability to minimize neuroinflammation by drug therapy may influence disease development. The CNS is endowed with an enlarged response repertoire named 'neuroinflammation', which enables it to cope with pathogens, toxins, traumata and degeneration. 

• Track 9-1Chemokines Signaling
• Track 9-2Neurologic Emergencies
• Track 9-3Inflammatory Markers
• Track 9-4Chronic Inflammation

Track 8 : Neurogenetics

Neurogenetics is an important discipline which deals with the most exciting translational clinical and basic research in neurology and human genetics. Several of the essential processes underlying neurological disease remain indefinable and/or poorly understood. Genetics and proteomics (the study of proteins produced by genes) can enhance our understanding of predisposition to diseases so we can build the next wave of therapies to treat neurological disease. Advances in genomics and emerging technologies has helped to better outline neurological syndromes, understand neurological disease progression, and refine clinical treatments.

• Track 8-1Huntington disease
• Track 8-2Gene defect and diseases
• Track 8-3Cancer genetics
• Track 8-4Biochemical genetics

Track 6 : Neuropsychiatry and Behavioral Science

Neuropsychiatry is a branch of medicine that deals with mental disorders attributable to diseases of the nervous system. It preceded the current disciplines of psychiatry and neurology. Neurologists have focused objectively on organic nervous system pathology, especially of the brain, whereas psychiatrists have laid claim to illnesses of the mind. Major Neuropsychiatric Conditions include the following: Addictions, Childhood and development, Eating disorders, Degenerative diseases, Mood disorders, Neurotic disorders, Psychosis & Sleep disorders.

Behavioral science is a subject that inter links the activities and interactions among organisms in world. It is the systematic analysis of human behaviour through experiments and observations. Observation and experiments are the two main sources of Behavioral Science. Behavioral science is a domain that involves various other fields.

• Track 6-1Dementia
• Track 6-2Neuropsychiatry Stroke
• Track 6-3Different Classes of Observations and Experiments
• Track 6-4Speech and Behaviour